Table 2 Outcome changes during COVID-19 pandemic in MOH patients
Outcome | MOH patientsa |
|---|---|
Change in headache days per month | |
Increase | 13 (16.7%) |
Unchanged | 42 (53.8%) |
Decrease | 23 (29.5%) |
50% reduction | 16 (20.5%) |
Change in headache intensity per month | |
Increase | 8 (10.3%) |
Unchanged | 43 (55.1%) |
Decrease | 27 (34.6%) |
Change in days per month with acute medication | |
Increase | 11 (14.1%) |
Unchanged | 46 (59.0%) |
Decrease | 21 (26.9%) |
Change from medication overuse to non-overuse | 9 (11.5%) |